SCHEMBL3490503

SCHEMBL3490503

C[C@@H]1C[C@]23CC[C@H]4C(C)(C)CCC[C@]4(C)[C@H]2CC[C@@]1(O)C3

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.44
F10 P00742 4/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP19A1 P11511 1/20 0.39
POLB P06746 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C19 P33261 2/20 0.38
PTPN1 P18031 4/20 0.36
HSD11B2 P80365 1/20 0.35
PTPN2 P17706 1/20 0.35
CDC25B P30305 1/20 0.35
IDO1 P14902 1/20 0.35
TRPV1 Q8NER1 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3490504 1.00 HSD11B1 (0.44) HSD11B1F10MEN1KMT2ACYP19A1
SCHEMBL13401496 1.00 HSD11B1 (0.44) HSD11B1F10MEN1KMT2ACYP19A1
SCHEMBL13401639 0.82 F10 (0.64) HSD11B1F10MEN1KMT2APOLB
SCHEMBL13401677 0.82 F10 (0.64) HSD11B1F10MEN1KMT2APOLB
SCHEMBL13401670 0.79 MEN1 (0.66) HSD11B1F10MEN1KMT2APOLB
SCHEMBL16335449 0.77 HSD11B1 (0.56) HSD11B1F10MEN1KMT2ACYP19A1
SCHEMBL3493333 0.77 HSD11B1 (0.56) HSD11B1F10MEN1KMT2ACYP19A1
SCHEMBL30111361 0.77 HSD11B1 (0.56) HSD11B1F10MEN1KMT2ACYP19A1
SCHEMBL3493335 0.77 HSD11B1 (0.56) HSD11B1F10MEN1KMT2ACYP19A1
SCHEMBL16335450 0.77 HSD11B1 (0.56) HSD11B1F10MEN1KMT2ACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100099640-A1 TISSUE DEGENERATION PROTECTION GEUNS JOANNES 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099640-A1 TISSUE DEGENERATION PROTECTION SORD, CASP3, TXNRD2 HSD11B1 187/4885F10 551/4885MEN1 3683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.